A vaccine against COVID-19

“Analysis of the COVID-19 virus has shown us that it has properties that are directly related to the molecules we develop at Glycovax Pharma. This discovery allows us to envision a solution that could be deployed quickly enough to counter this virus. It is a disruptive scientific strategy that we have a duty to explore”, said René Roy, QCAM member and VP of Research at the company he co-founded, Glycovax Pharma.